BACKGROUND AND OBJECTIVES: Central nervous system (CNS) stimulants may be used to reduce tiredness and increase alertness, competitiveness, and aggression. They are more likely to be used in competition but may be used during training to increase the intensity of the training session. There are several potential dangers involving their misuse in contact sports. This paper reviews the three main CNS stimulants, ephedrine, amfetamine, and cocaine, in relation to misuse in sport. METHODS: Description of the pharmacology, actions, and side effects of amfetamine, cocaine, and ephedrine. RESULTS: CNS stimulants have psychotropic effects that may be perceived to be ergogenic. Some are prescription drugs, such as Ephedra alkaloids, and there are issues regarding their appropriate therapeutic use. Recently attention has been given to their widespread use by athletes, despite the lack of evidence regarding any ergogenic or real performance benefit, and their potentially serious side effects. Recreational drugs, some of which are illegal (cocaine, amfetamines), are commonly used by athletes and cause potential ergolytic effects. Overall, these drugs are important for their frequent use and mention in anti-doping laboratories statistics and the media, and their potentially serious adverse effects. CONCLUSIONS: Doping with CNS stimulants is a real public health problem and all sports authorities should participate in its prevention. Dissemination of information is essential to prevent doping in sport and to provide alternatives. Adequate training and education in this domain should be introduced.
BACKGROUND AND OBJECTIVES: Central nervous system (CNS) stimulants may be used to reduce tiredness and increase alertness, competitiveness, and aggression. They are more likely to be used in competition but may be used during training to increase the intensity of the training session. There are several potential dangers involving their misuse in contact sports. This paper reviews the three main CNS stimulants, ephedrine, amfetamine, and cocaine, in relation to misuse in sport. METHODS: Description of the pharmacology, actions, and side effects of amfetamine, cocaine, and ephedrine. RESULTS: CNS stimulants have psychotropic effects that may be perceived to be ergogenic. Some are prescription drugs, such as Ephedra alkaloids, and there are issues regarding their appropriate therapeutic use. Recently attention has been given to their widespread use by athletes, despite the lack of evidence regarding any ergogenic or real performance benefit, and their potentially serious side effects. Recreational drugs, some of which are illegal (cocaine, amfetamines), are commonly used by athletes and cause potential ergolytic effects. Overall, these drugs are important for their frequent use and mention in anti-doping laboratories statistics and the media, and their potentially serious adverse effects. CONCLUSIONS: Doping with CNS stimulants is a real public health problem and all sports authorities should participate in its prevention. Dissemination of information is essential to prevent doping in sport and to provide alternatives. Adequate training and education in this domain should be introduced.
Authors: Adam J Wells; Jay R Hoffman; Adam M Gonzalez; Kyle S Beyer; Adam R Jajtner; Jeremy R Townsend; Leonardo P Oliveira; David H Fukuda; Maren S Fragala; Jeffrey R Stout Journal: J Int Soc Sports Nutr Date: 2014-12-10 Impact factor: 5.150
Authors: Maha Sellami; Olfa Slimeni; Andrzej Pokrywka; Goran Kuvačić; Lawrence D Hayes; Mirjana Milic; Johnny Padulo Journal: J Int Soc Sports Nutr Date: 2018-03-15 Impact factor: 5.150
Authors: Yajuan Li; Yaohua Zhang; Qingsong Hu; Sergey D Egranov; Zhen Xing; Zhao Zhang; Ke Liang; Youqiong Ye; Yinghong Pan; Sujash S Chatterjee; Brandon Mistretta; Tina K Nguyen; David H Hawke; Preethi H Gunaratne; Mien-Chie Hung; Leng Han; Liuqing Yang; Chunru Lin Journal: Genome Med Date: 2021-08-28 Impact factor: 11.117
Authors: Daniel Radiloff; Yulin Zhao; Alina Boico; Gert Blueschke; Gregory Palmer; Andrew Fontanella; Mark Dewhirst; Claude A Piantadosi; Robert Noveck; David Irwin; Karyn Hamilton; Bruce Klitzman; Thies Schroeder Journal: PLoS One Date: 2014-06-24 Impact factor: 3.240